Company intelligence / Profile preview

Novasys Medical

Newark, California, United States

Ownership: Private
Development stage: Other

Overview

Novasys Medical was a medical technology company that developed and commercialized therapies for women's health, specifically focusing on stress urinary incontinence (SUI). The company's primary product, the Renessa System, is a non-surgical, office-based treatment that uses transurethral radiofrequency energy to remodel the collagen in the bladder neck and urethra. This procedure is designed to provide a less invasive alternative to surgical slings for women suffering from SUI. Novasys Medical was acquired by Roper Industries (now Roper Technologies) in 2012 and integrated into its Verathon medical device subsidiary.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Novasys Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novasys Medical.

Explore the full profile